221 related articles for article (PubMed ID: 28801976)
1. Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies.
Grati FR; Bajaj K; Zanatta V; Malvestiti F; Malvestiti B; Marcato L; Grimi B; Maggi F; Simoni G; Gross SJ; Ferreira J
Prenat Diagn; 2017 Oct; 37(10):1017-1027. PubMed ID: 28801976
[TBL] [Abstract][Full Text] [Related]
2. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
[TBL] [Abstract][Full Text] [Related]
3. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
[TBL] [Abstract][Full Text] [Related]
4. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal mosaicism in the fetoplacental unit.
Grati FR; Malvestiti F; Branca L; Agrati C; Maggi F; Simoni G
Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():39-52. PubMed ID: 28284509
[TBL] [Abstract][Full Text] [Related]
6. Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.
Benn P; Malvestiti F; Grimi B; Maggi F; Simoni G; Grati FR
Ultrasound Obstet Gynecol; 2019 Oct; 54(4):458-467. PubMed ID: 31237735
[TBL] [Abstract][Full Text] [Related]
7. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
[TBL] [Abstract][Full Text] [Related]
8. Increased nuchal translucency, hydrops fetalis or hygroma colli. A new test strategy for early fetal aneuploidy detection.
Jenderny J; Schmidt W; Hecher K; Hackelöer BJ; Kerber S; Kochhan L; Held KR
Fetal Diagn Ther; 2001; 16(4):211-4. PubMed ID: 11399881
[TBL] [Abstract][Full Text] [Related]
9. Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism.
Chen CP; Tsai C; Lin MH; Chern SR; Chen SW; Lai ST; Chen WL; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2017 Oct; 56(5):691-693. PubMed ID: 29037560
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of mosaicism and uniparental disomy in amniocytes, after detection of mosaic chromosome abnormalities in chorionic villi.
Grati FR; Grimi B; Frascoli G; Di Meco AM; Liuti R; Milani S; Trotta A; Dulcetti F; Grosso E; Miozzo M; Maggi F; Simoni G
Eur J Hum Genet; 2006 Mar; 14(3):282-8. PubMed ID: 16418738
[TBL] [Abstract][Full Text] [Related]
12. Prospective ranking of the sonographic markers for aneuploidy: data of 2143 prenatal cytogenetic diagnoses referred for abnormalities on ultrasound.
Daniel A; Athayde N; Ogle R; George AM; Michael J; Pertile MD; Bryan J; Jammu V; Trudinger BJ
Aust N Z J Obstet Gynaecol; 2003 Feb; 43(1):16-26. PubMed ID: 12755342
[TBL] [Abstract][Full Text] [Related]
13. Chorionic villus sampling in the cell-free DNA aneuploidy screening era: careful selection criteria can maximise the clinical utility of screening and invasive testing.
Kane SC; Reidy KL; Norris F; Nisbet DL; Kornman LH; Palma-Dias R
Prenat Diagn; 2017 Apr; 37(4):399-408. PubMed ID: 28207933
[TBL] [Abstract][Full Text] [Related]
14. Fetoplacental chromosomal discrepancy.
Farra C; Giudicelli B; Pellissier MC; Philip N; Piquet C
Prenat Diagn; 2000 Mar; 20(3):190-3. PubMed ID: 10719319
[TBL] [Abstract][Full Text] [Related]
15. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results.
Grati FR; Malvestiti F; Ferreira JC; Bajaj K; Gaetani E; Agrati C; Grimi B; Dulcetti F; Ruggeri AM; De Toffol S; Maggi F; Wapner R; Gross S; Simoni G
Genet Med; 2014 Aug; 16(8):620-4. PubMed ID: 24525917
[TBL] [Abstract][Full Text] [Related]
16. A pregnancy with discordant fetal and placental chromosome 18 aneuploidies revealed by invasive and noninvasive prenatal diagnosis.
Chen C; Cram DS; Xie F; Wang P; Xu X; Li H; Song Z; Chen D; Zhang J; Tang S
Reprod Biomed Online; 2014 Jul; 29(1):136-9. PubMed ID: 24797099
[TBL] [Abstract][Full Text] [Related]
17. Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and Performance.
Bevilacqua E; Ordóñez E; Hurtado I; Rueda L; Mazzone E; Cirigliano V; Jani JC
Fetal Diagn Ther; 2018; 44(2):98-104. PubMed ID: 28848190
[TBL] [Abstract][Full Text] [Related]
18. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome.
Viuff MH; Stochholm K; Uldbjerg N; Nielsen BB; ; Gravholt CH
Hum Reprod; 2015 Oct; 30(10):2419-26. PubMed ID: 26251461
[TBL] [Abstract][Full Text] [Related]
19. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
20. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?
Mennuti MT; Cherry AM; Morrissette JJ; Dugoff L
Am J Obstet Gynecol; 2013 Nov; 209(5):415-9. PubMed ID: 23529082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
